Risky business: risk perception and the use of medical services among customers of DTC personal genetic testing.
about
Personal genome testing in medical education: student experiences with genotyping in the classroomEvolving approaches to the ethical management of genomic dataInternet-Based Direct-to-Consumer Genetic Testing: A Systematic ReviewPublic preferences for the return of research results in genetic research: a conjoint analysisDiet and exercise changes following direct-to-consumer personal genomic testing.Does personal genome testing drive service utilization in an adult preventive medicine clinic?Comparison of commercial genetic-testing services in Korea with 23andMe service.Implementation and utilization of genetic testing in personalized medicine.Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents.Disclosure of genetic information and change in dietary intake: a randomized controlled trial.Genetics and treatment options for recurrent acute and chronic pancreatitis.Design, methods, and participant characteristics of the Impact of Personal Genomics (PGen) Study, a prospective cohort study of direct-to-consumer personal genomic testing customers.The undiscovered country: the future of integrating genomic information into the EHRPrevalence and correlates of receiving and sharing high-penetrance cancer genetic test results: findings from the Health Information National Trends Survey.Informing the Design of Direct-to-Consumer Interactive Personal Genomics Reports.Explaining, not just predicting, drives interest in personal genomics.To ban or not to ban? Clinical geneticists' views on the regulation of direct-to-consumer genetic testing.State of play in direct-to-consumer genetic testing for lifestyle-related diseases: market, marketing content, user experiences and regulation.Patients' views on incidental findings from clinical exome sequencing.Influence of individual differences in disease perception on consumer response to direct-to-consumer genomic testing."Is it really worth it to get tested?": primary care patients' impressions of predictive SNP testing for colon cancer.Was it worth it? Patients' perspectives on the perceived value of genomic-based individualized medicine.Translational Genomic Research: Protocol Development and Initial Outcomes following SNP Testing for Colon Cancer Risk.Dealing with the unexpected: consumer responses to direct-access BRCA mutation testingAssessment of presurgical psychological screening in patients undergoing spine surgery: use and clinical impact.Attitudes about regulation among direct-to-consumer genetic testing customers.Incorporating direct-to-consumer genomic information into patient care: attitudes and experiences of primary care physiciansHow Well Do Customers of Direct-to-Consumer Personal Genomic Testing Services Comprehend Genetic Test Results? Findings from the Impact of Personal Genomics StudyBehavioral and psychosocial responses to genomic testing for colorectal cancer risk.Adopting genetics: motivations and outcomes of personal genomic testing in adult adoptees.Primary care patients' views and decisions about, experience of and reactions to direct-to-consumer genetic testing: a longitudinal study.Direct-to-Consumer Genetic Testing and Personal Genomics Services: A Review of Recent Empirical StudiesOpportunities for genomic clinical decision support interventions.Pharmacogenomics and patient care: one size does not fit all.My46: a Web-based tool for self-guided management of genomic test results in research and clinical settingsPrescription medication changes following direct-to-consumer personal genomic testing: findings from the Impact of Personal Genomics (PGen) Study.Promoting healthy dietary behaviour through personalised nutrition: technology push or technology pull?Transparency of genetic testing services for 'health, wellness and lifestyle': analysis of online prepurchase information for UK consumers.Discussing molecular testing in oncology care: Comparing patient and physician information preferences.Knowing your genes: does this impact behaviour change?
P2860
Q21183965-BCFB8DA1-E57D-4014-9BE8-710D8EC5560CQ24618993-E9A4041E-75E0-4E25-AAFF-17E554F97666Q26775070-45C05A4F-51C5-45DF-9D50-5C6A2CBD53BEQ27324226-232F3CFD-973F-47B5-8DB8-B8D492302994Q33623616-EB331473-6FC3-4025-8FEA-4C06524F6444Q33870450-4ECF0175-83C0-4287-83FD-D08E545CAEE2Q33892611-176E3468-C5C8-4D4F-95EB-CB394855A490Q34147916-4DC43287-7E17-4BCA-92AA-F433B7720AF8Q34483451-39F861B5-D993-4FC1-913F-E0F5D2B4CE98Q34513835-4BB621BD-A5A8-4FA9-9B35-28E5DC60F667Q34581965-BFCEF7A1-B417-4C2F-AA21-8F1B323D3FC2Q34636079-63D91B37-49E1-4B2A-99A9-EB5F9390E623Q34653257-E74212C9-2A0C-4F86-AED4-98FE7BAE724BQ35513354-5728343E-D31E-4AEB-818B-E9482DF2AD11Q35922365-82E9FFA5-FCDC-4C62-AB77-DB73E6FC3233Q35945361-C2B6E920-41B7-45F0-8A3E-D549673854B6Q36205429-E2B0972F-5985-4822-8909-D9FB6229A1B3Q36551257-DDC21AFA-C548-4ABD-B711-83A5D48C7C48Q36556501-D2E64325-B493-4118-A054-3288A795B936Q36593395-2DDDB489-BFF9-4A04-B7DB-0B949C6486ABQ36595655-23DDD71C-EAEE-48BC-BB8E-938C9D481E4EQ36698414-84EFF538-C502-4545-86BC-7598C7C08CCBQ36738056-EADDBDD4-4B92-438D-94EB-8BBE763D4A63Q36773744-09D1689A-2B72-4AA9-BEA2-0635C07B5F5DQ36774156-A4B52E15-BA34-478C-90A3-822FA3853CC6Q36789414-F21256B7-EF91-4100-98D1-0B9FCE5392DEQ36935684-0F0878AA-A4DC-41EC-BAD1-D166D686B9CCQ37050375-E7C1B154-FCF8-4578-83C1-DABE258E3CDEQ37060585-126E6EE8-9EAE-4575-8676-49C3C98B0AB3Q37136376-EB5CBF72-7D43-49DE-AF2E-7C905DC382ADQ37171548-25282020-34B0-4644-AADD-4AF0835D83DAQ37184695-27015F47-5BEE-4F1C-AA11-DC0ED7DBB616Q37380732-EA3F1052-896B-4E06-9E05-91E408D233D8Q37658586-6709A28D-B29C-4778-8D10-494032296689Q37702883-38FED51A-5CA4-4BCE-ABD7-E1586893DB8EQ37716304-FC1EB05B-7515-4716-A4A3-8CD39C5C6EB5Q38262443-DFD50E89-67C4-4E6C-BF5D-2BDA8C56795DQ38681364-1B0C58A3-6DAC-4F61-841E-8DA3556C395FQ38763892-D26281AC-7B8D-4AD9-B1DD-F76742BF49FEQ38768364-6F37A1C4-E2E8-41E4-A34B-E6BA9A78E03B
P2860
Risky business: risk perception and the use of medical services among customers of DTC personal genetic testing.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Risky business: risk perceptio ...... DTC personal genetic testing.
@en
Risky business: risk perceptio ...... DTC personal genetic testing.
@nl
type
label
Risky business: risk perceptio ...... DTC personal genetic testing.
@en
Risky business: risk perceptio ...... DTC personal genetic testing.
@nl
prefLabel
Risky business: risk perceptio ...... DTC personal genetic testing.
@en
Risky business: risk perceptio ...... DTC personal genetic testing.
@nl
P2093
P2860
P1476
Risky business: risk perceptio ...... DTC personal genetic testing.
@en
P2093
David J Kaufman
Joan A Scott
Juli M Bollinger
Rachel L Dvoskin
P2860
P304
P356
10.1007/S10897-012-9483-0
P577
2012-01-26T00:00:00Z